Rani Therapeutics Holdings recently announced a collaboration and license agreement with Chugai Pharmaceutical for the joint development and commercialization of an oral product combining Rani’s ...
Nano-cap biotherapeutics company Rani Therapeutics (NASDAQ:RANI) surged over 200% on Friday after the drug developer announced a licensing deal with Japanese pharma giant Chugai Pharmaceutical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback